Crinetics Pharmaceuticals, Inc. ( CRNX) - Key Metrics
CRNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.04 | -$1.31 | -$0.99 | -$0.99 |
| 2025Q3 | $0 | -$1.38 | -$1.18 | -$1.18 |
| 2025Q2 | $0.01 | -$1.23 | -$0.92 | -$0.95 |
| 2025Q1 | $0 | -$1.04 | -$0.95 | -$0.96 |
CRNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.91 |
| 2025Q3 | ? | -7.54 |
| 2025Q2 | ? | -5.83 |
| 2025Q1 | ? | -8.07 |
CRNX
Price: $35.12
52 week price:
Earnings Per Share: -5.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 265100
Market Capitalization: 3.5 billion